68
Taiwan Bio Therapeutics Co., Ltd
6892.TWO · TWO
$26.90 -1.82% (-$0.50)
1M +12.94%
Market Cap $2.56B
P/E Ratio -
Div. Yield -
ROE 42.93%
Piotroski F-Score Weak
2/9Valuation
35 /100
Fair P/B 2.85x
P/S 24.97x
EV/EBITDA N/A
Growth
50 /100
Stable Book val. growth 11.46%
Rev. growth 4.06%
FCF growth N/A
Profitability
20 /100
Weak Net margin 396.79%
Op. margin 385.07%
FCF margin 293.37%
Quality
1 /100
Poor ROE 42.93%
ROA 31.48%
Asset turnover 0.08x
Debt
66 /100
Moderate Current ratio 8.15x
Int. coverage -65.24x
Debt/Equity 0.37x
Stability
34 /100
Moderate Rev. volatility 71.54%
EPS volatility 15.13%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6892.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chun Yao Yang
Employees
20
Headquarters
Taipei City